Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature (Q38151920)

29 August 2017

title

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature (English)

1 reference

29 August 2017

1 reference

1 reference

1

Sven Jarius

1 reference

29 August 2017

2

Brigitte Wildemann

1 reference

29 August 2017

publication date

1 November 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

23

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

661-683

1 reference

Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis

29 August 2017

cites work

1 reference

Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport

21 January 2018

1 reference

AQP4-IgG immunoprecipitation assay optimization.

21 January 2018

1 reference

Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.

21 January 2018

1 reference

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

21 January 2018

1 reference

Importance of cerebrospinal fluid examination in differential diagnosis of Devic?s neuromyelitis optica by multiple sclerosis

21 January 2018

1 reference

Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations

21 January 2018

1 reference

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution

21 January 2018

1 reference

Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays

21 January 2018

1 reference

Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays

21 January 2018

1 reference

Neuromyelitis optica in France: a multicenter study of 125 patients

21 January 2018

1 reference

Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells

21 January 2018

1 reference

Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays

21 January 2018

1 reference

21 January 2018

1 reference

Diagnostic tests 4: likelihood ratios

21 January 2018

1 reference

Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases.

21 January 2018

1 reference

New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies

21 January 2018

1 reference

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies

21 January 2018

1 reference

Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.

21 January 2018

1 reference

Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.

21 January 2018

1 reference

Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms

21 January 2018

1 reference

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

21 January 2018

1 reference

Detection of IgM responses to bovine respiratory syncytial virus by indirect ELISA following experimental infection and reinfection of calves: abolition of false positive and false negative results by pre-treatment of sera with protein-G agarose

21 January 2018

1 reference

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology

21 January 2018

1 reference

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay

21 January 2018

1 reference

Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection

21 January 2018

1 reference

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

21 January 2018

1 reference

Implications of the aquaporin-4 structure on array formation and cell adhesion.

21 January 2018

1 reference

Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance

21 January 2018

1 reference

Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays

21 January 2018

1 reference

Gluten sensitivity and neuromyelitis optica: two case reports

21 January 2018

1 reference

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

21 January 2018

1 reference

An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS.

21 January 2018

1 reference

The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation

21 January 2018

1 reference

'Noteomielite' accompanied by acute amaurosis (1844). An early case of neuromyelitis optica

21 January 2018

1 reference

The history of neuromyelitis optica

21 January 2018

1 reference

On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica

21 January 2018

1 reference

NMO-IgG in the diagnosis of neuromyelitis optica

21 January 2018

1 reference

Revised diagnostic criteria for neuromyelitis optica—incorporation of NMO-IgG status

21 January 2018

1 reference

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

21 January 2018

1 reference

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica

21 January 2018

1 reference

Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders

21 January 2018

1 reference

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance

21 January 2018

1 reference

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

21 January 2018

1 reference

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen

21 January 2018

1 reference

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.

21 January 2018

1 reference

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

21 January 2018

1 reference

Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.

21 January 2018

1 reference

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

21 January 2018

1 reference

Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders

21 January 2018

1 reference

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

21 January 2018

1 reference

Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature

21 January 2018

1 reference

Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica

21 January 2018

1 reference

Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica

21 January 2018

1 reference

Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes

21 January 2018

1 reference

Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder

21 January 2018

1 reference

NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy

21 January 2018

1 reference

Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients

21 January 2018

1 reference

Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels

21 January 2018

1 reference

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.

21 January 2018

1 reference

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders

21 January 2018

1 reference

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

21 January 2018

1 reference

NMO-IgG detected in CSF in seronegative neuromyelitis optica

21 January 2018

1 reference

Failure of natalizumab to prevent relapses in neuromyelitis optica.

21 January 2018

1 reference

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

21 January 2018

1 reference

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients

21 January 2018

1 reference

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

Neuromyelitis optica immunoglobulin G in Chinese patients detected by immunofluorescence assay on a monkey brain substrate

21 January 2018

1 reference

Clinical features of Chinese patients with multiple sclerosis with aquaporin-4 antibodies in cerebrospinal fluid but not serum

21 January 2018

1 reference

Spectrum of pediatric neuromyelitis optica

21 January 2018

1 reference

Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica

21 January 2018

1 reference

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

21 January 2018

1 reference

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

NMO-IgG and Devic's neuromyelitis optica: a French experience.

21 January 2018

1 reference

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

21 January 2018

1 reference

Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese

21 January 2018

1 reference

Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status

21 January 2018

1 reference

21 January 2018

1 reference

Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.

21 January 2018

1 reference

CNS aquaporin-4 autoimmunity in children

21 January 2018

1 reference

Epidemiology of neuromyelitis optica in the United States: a multicenter analysis

21 January 2018

1 reference

IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies

21 January 2018

1 reference

Seroconversion of anti-aquaporin-4 antibody in NMO spectrum disorder: a case report

21 January 2018

1 reference

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies

21 January 2018

1 reference

A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset

21 January 2018

1 reference

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

21 January 2018

1 reference

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

21 January 2018

1 reference

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

21 January 2018

1 reference

Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding

21 January 2018

1 reference

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

Evidences for a leaky scanning mechanism for the synthesis of the shorter M23 protein isoform of aquaporin-4: implication in orthogonal array formation and neuromyelitis optica antibody interaction

21 January 2018

1 reference

Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study

21 January 2018

1 reference

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

21 January 2018

1 reference

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica

21 January 2018

1 reference

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

21 January 2018

1 reference

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

21 January 2018

1 reference

Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions

21 January 2018

1 reference

Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica

21 January 2018

1 reference

Diagnostik und Therapie der Neuromyelitis optica

21 January 2018

1 reference

Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis

21 January 2018

1 reference

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

21 January 2018

1 reference

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

21 January 2018

1 reference

21 January 2018

1 reference

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

The spectrum of neuromyelitis optica

21 January 2018

1 reference

Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status

21 January 2018

1 reference

Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus

21 January 2018

1 reference

Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels

21 January 2018

1 reference

OSMS is NMO, but not MS: proven clinically and pathologically

21 January 2018

1 reference

Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica

21 January 2018

1 reference

Anti–Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic Neuritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BPA.12084

1 reference

29 August 2017

1 reference